4 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Dr Adnan Agha: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism Vitamin C, Oral Rehydration Salt Formulations - Hypothyroidism, Primary Hypothyroidism | Phase 2 | Unknown | Dr Adnan Agha | 40 | 2023-11-01 | 2024-01-11 |
| Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue GIP/GLP-1a - Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis | Phase 1 / Phase 2 | Unknown | Dr Adnan Agha | 30 | 2023-10-01 | 2024-01-12 |
| Assessing Baseline Cortisol Levels in Patients Admitted With Septic Shock in Intensive Care Unit Retrospective chart review - Critical Illness, Adrenal Insufficiency | Unknown | Dr Adnan Agha | 50 | 2023-01-31 | 2024-01-11 | |
| Validation of Prognostic Clinical Risk Scores in Predicting Outcome for Patients With COVID-19 at Initial Triage logistic regression of known prognostic markers of severity of COVID19 - COVID-19 | Unknown | Dr Adnan Agha | 2000 | 2023-01-01 | 2023-02-06 |
Adrenal Insufficiency (1) · Ascorbic Acid Deficiency (1) · COVID-19 (1) · Critical Illness (1) · Diabetes Mellitus, Type 2 (1) · Fatty Liver (1) · Hypothyroidism (1) · Non-alcoholic Fatty Liver Disease (1) · Shock, Septic (1)
Ascorbic Acid (1)
United Arab Emirates (4)
Adnan Agha (3) · Adnan Agha, FRCP (1)